Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lionne D F Venderbos

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Asian Journal of Andrology|February 8, 2011
PSA-based prostate cancer screening: the role of active surveillance and informed and shared decision makingLionne D F Venderbos, Monique J Roobol
Translational Andrology and Urology|March 30, 2018
eHealth and mHealth in prostate cancer detection and active surveillanceNuno M Pereira-Azevedo, Lionne D F Venderbos
Current Opinion in Urology|March 3, 2015
Disease-specific and patient-reported outcomes under active surveillanceLionne D F Venderbos, Chris H Bangma, Ida J Korfage
Current Opinion in Urology|February 22, 2013
Active surveillance: oncologic outcomeLionne D F Venderbos, Leonard P Bokhorst, Chris H Bangma, et al.
Translational Andrology and Urology|June 12, 2023
A literature review to understand health literacy in men with prostate cancer on active surveillanceKatharina Beyer, Sebastiaan Remmers, Mieke Van Hemelrijck, et al.
BJU International|May 13, 2017
Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate CancerPeter K Chiu, Arnout R Alberts, Lionne D F Venderbos, et al.
BJU International|March 17, 2026
Empowering choices: insights from healthcare professionals on shared decision-making in kidney cancerKatharina Beyer, Lionne D F Venderbos, Olivier Exertier, et al.
European Urology Open Science|August 1, 2022
Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer RotterdamRenée Hogenhout, Ivo I de Vos, Sebastiaan Remmers, et al.
European Urology Open Science|January 13, 2025
Impact of Additional Active Treatment for Prostate Cancer on Health-related Quality of Life of Men: Results from the EUPROMS 2.0 1-year Follow-up SurveyLionne D F Venderbos, Sebastiaan Remmers, André Deschamps, et al.
Translational Andrology and Urology|July 23, 2021
Using the Movember Foundation's GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function-a retrospective study in low-risk prostate cancer patientsR Trafford Crump, Sebastiaan Remmers, Mieke Van Hemelrijck, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Asian Journal of Andrology|February 8, 2011
PSA-based prostate cancer screening: the role of active surveillance and informed and shared decision makingLionne D F Venderbos, Monique J Roobol
Translational Andrology and Urology|March 30, 2018
eHealth and mHealth in prostate cancer detection and active surveillanceNuno M Pereira-Azevedo, Lionne D F Venderbos
Current Opinion in Urology|March 3, 2015
Disease-specific and patient-reported outcomes under active surveillanceLionne D F Venderbos, Chris H Bangma, Ida J Korfage
Current Opinion in Urology|February 22, 2013
Active surveillance: oncologic outcomeLionne D F Venderbos, Leonard P Bokhorst, Chris H Bangma, et al.
Translational Andrology and Urology|June 12, 2023
A literature review to understand health literacy in men with prostate cancer on active surveillanceKatharina Beyer, Sebastiaan Remmers, Mieke Van Hemelrijck, et al.
BJU International|May 13, 2017
Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate CancerPeter K Chiu, Arnout R Alberts, Lionne D F Venderbos, et al.
BJU International|March 17, 2026
Empowering choices: insights from healthcare professionals on shared decision-making in kidney cancerKatharina Beyer, Lionne D F Venderbos, Olivier Exertier, et al.
European Urology Open Science|August 1, 2022
Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer RotterdamRenée Hogenhout, Ivo I de Vos, Sebastiaan Remmers, et al.
European Urology Open Science|January 13, 2025
Impact of Additional Active Treatment for Prostate Cancer on Health-related Quality of Life of Men: Results from the EUPROMS 2.0 1-year Follow-up SurveyLionne D F Venderbos, Sebastiaan Remmers, André Deschamps, et al.
Translational Andrology and Urology|July 23, 2021
Using the Movember Foundation's GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function-a retrospective study in low-risk prostate cancer patientsR Trafford Crump, Sebastiaan Remmers, Mieke Van Hemelrijck, et al.
Pageof 5